Division 6 The following particulars shall appear on the immediate and the outer packaging:
United Kingdom
- (a)
name of the main contact;
- (b)
name of the medicinal product, followed by its strength and pharmaceutical form;
- (c)
statement of the active substances expressed qualitatively and quantitatively per dosage unit;
- (d)
batch or code number identifying the contents and packaging operation;
- (e)
clinical trial reference code allowing identification of the clinical trial site, investigator and subject;
- (f)
directions for use (reference may be made to a leaflet or other explanatory document intended for the subject or person administering the product);
- (g)
’For clinical trial use only’ or similar wording;
- (h)
the storage conditions; and
- (i)
period of use (expiry date or retest date as applicable).